Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.245 USD | -5.77% | -0.58% | -86.75% |
Apr. 15 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
Apr. 12 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.75% | 5.14M | |
+0.44% | 42.86B | |
+12.60% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.85% | 25.15B | |
-23.56% | 18.63B | |
+27.69% | 12.37B | |
-3.64% | 11.92B | |
+6.70% | 11.21B |
- Stock Market
- Equities
- PRTG Stock
- News Portage Biotech Inc.
- Cantor Fitzgerald Adjusts Price Target on Portage Biotech to $11 From $16, Maintains Overweight Rating